Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to trulyRead More
Subscribe To Fenway Focus
Fenway Health has served the LGBT community, those affected by HIV, and our other members of our community in Boston’s Fenway neighborhood and beyond for the last 40 years. Learn more about Fenway Health; our research arm, The Fenway Institute; and the Sidney Borum, Jr. Health Center, which provides safe, non-judgmental care for young people ages 12–29 who may not feel comfortable going anywhere else.
Affordable Care Act AIDS AIDS2012 AIDS Action Committee AIDS Walk Boston Audre Lorde Brunch behavioral health bisexual Construction Update Events Fundraisers Gender identity Harbor to the Bay Health care Health Disparities HIV HIV/AIDS HIV/AIDS Policy HIV prevention HIV Research HIV testing International AIDS Conference Lesbian health LGBT Aging Project LGBT health LGBT Health Research LGBT seniors LGBT Youth Mentions in the news men who have sex with men National LGBT Health Education Center news Pre-Exposure Prophylaxis PrEP The Fenway Institute trans Transgender Transgender Awareness Week Transgender Health Trans Health Trans Women Health Violence Recovery Program Women's Health Young Leaders Council young people